David E. Cochrane

2.5k total citations
62 papers, 2.1k citations indexed

About

David E. Cochrane is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Immunology. According to data from OpenAlex, David E. Cochrane has authored 62 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Molecular Biology, 37 papers in Cellular and Molecular Neuroscience and 19 papers in Immunology. Recurrent topics in David E. Cochrane's work include Neuropeptides and Animal Physiology (32 papers), Receptor Mechanisms and Signaling (22 papers) and Mast cells and histamine (16 papers). David E. Cochrane is often cited by papers focused on Neuropeptides and Animal Physiology (32 papers), Receptor Mechanisms and Signaling (22 papers) and Mast cells and histamine (16 papers). David E. Cochrane collaborates with scholars based in United States, United Kingdom and Austria. David E. Cochrane's co-authors include W. W. Douglas, Theoharis C. Theoharides, Robert E. Carraway, Ross S. Feldberg, William Boucher, J B Lansman, Takahiro Kanno, Brett M. Paterson, Susan E. Leeman and Jan A. Pechenik and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Oncology.

In The Last Decade

David E. Cochrane

61 papers receiving 2.0k citations

Peers

David E. Cochrane
David E. Cochrane
Citations per year, relative to David E. Cochrane David E. Cochrane (= 1×) peers Yoshihiro Morikawa

Countries citing papers authored by David E. Cochrane

Since Specialization
Citations

This map shows the geographic impact of David E. Cochrane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David E. Cochrane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David E. Cochrane more than expected).

Fields of papers citing papers by David E. Cochrane

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David E. Cochrane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David E. Cochrane. The network helps show where David E. Cochrane may publish in the future.

Co-authorship network of co-authors of David E. Cochrane

This figure shows the co-authorship network connecting the top 25 collaborators of David E. Cochrane. A scholar is included among the top collaborators of David E. Cochrane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David E. Cochrane. David E. Cochrane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
McEwan, Conor, Joshua Owen, Eleanor Stride, et al.. (2015). Oxygen carrying microbubbles for enhanced sonodynamic therapy of hypoxic tumours. Journal of Controlled Release. 203. 51–56. 236 indexed citations
3.
Pechenik, Jan A., et al.. (2007). Nitric Oxide Inhibits Metamorphosis in Larvae ofCrepidula fornicata, the Slippershell Snail. Biological Bulletin. 213(2). 160–171. 46 indexed citations
4.
Scarpa, Richard C., Robert E. Carraway, & David E. Cochrane. (2005). Insulin-like growth factor (IGF) induced proliferation of human lung fibroblasts is enhanced by neurotensin. Peptides. 26(11). 2201–2210. 13 indexed citations
5.
Scarpa, Richard C., Robert E. Carraway, & David E. Cochrane. (2004). The effect of neurotensin on insulin-induced proliferation of human fibroblasts. Peptides. 25(7). 1159–1169. 6 indexed citations
6.
Theoharides, Theoharis C. & David E. Cochrane. (2003). Critical role of mast cells in inflammatory diseases and the effect of acute stress. Journal of Neuroimmunology. 146(1-2). 1–12. 336 indexed citations
7.
Carraway, Robert E., Sankar Mitra, & David E. Cochrane. (2000). Pro-xenopsin(s) in vesicles of mammalian brain, liver, stomach and intestine is apparently released into blood and cerebral spinal fluid. Regulatory Peptides. 95(1-3). 115–124. 1 indexed citations
8.
Harris, Margaret T., Ross S. Feldberg, Kin‐Mang Lau, Nicole H. Lazarus, & David E. Cochrane. (2000). Expression of proinflammatory genes during estrogen-induced inflammation of the rat prostate. The Prostate. 44(1). 19–25. 81 indexed citations
9.
Miller, Lisa A., David E. Cochrane, Ross S. Feldberg, & Robert E. Carraway. (1998). Inhibition of Neurotensin-Stimulated Mast Cell Secretion and Carboxypeptidase A Activity by the Peptide Inhibitor of Carboxypeptidase A and Neurotensin-Receptor Antagonist SR 48692. International Archives of Allergy and Immunology. 116(2). 147–153. 7 indexed citations
10.
Feldberg, Ross S., et al.. (1998). Evidence for a neurotensin receptor in rat serosal mast cells. Inflammation Research. 47(6). 245–250. 32 indexed citations
11.
Miller, Lisa A., David E. Cochrane, Robert E. Carraway, & Ross S. Feldberg. (1993). Inhibitory effects of the neurotensin8–13 analogs Asp13-NT8–13 and Asp12-NT8–13 on mast cell secretion. Inflammation Research. 38(S1). 1–7. 20 indexed citations
12.
Cochrane, David E., Robert E. Carraway, Ross S. Feldberg, William Boucher, & Joel M. Gelfand. (1993). Stimulated rat mast cells generate histamine-releasing peptide from albumin. Peptides. 14(2). 117–123. 24 indexed citations
13.
Eldred, William D., et al.. (1992). Immunocytochemical and biochemical studies of histamine in the retina of the turtle Pseudemys scripta. Cell and Tissue Research. 267(3). 449–454.
14.
Cochrane, David E., Robert E. Carraway, & William Boucher. (1992). Histamine‐Releasing Peptide Is Formed from Albumin by Stimulated Rat Mast Cellsa. Annals of the New York Academy of Sciences. 668(1). 333–334. 2 indexed citations
15.
Carraway, Robert E., et al.. (1991). Neurotensin elevates hematocrit and plasma levels of the leukotrienes, LTB4, LTC4, LTD4 and LTE4, in anesthetized rats. Peptides. 12(5). 1105–1111. 26 indexed citations
16.
Cochrane, David E., Robert E. Carraway, & William Boucher. (1991). Generation of xenopsin-related peptides from tissue precursors by media conditioned by endotoxin-stimulated rat peritoneal macrophages. Inflammation. 15(5). 381–390. 7 indexed citations
17.
Cochrane, David E., Robert E. Carraway, William Boucher, & Ross S. Feldberg. (1991). Rapid degradation of neurotensin by stimulated rat mast cells. Peptides. 12(6). 1187–1194. 33 indexed citations
18.
Cochrane, David E.. (1990). 4 Peptide Regulation of Mast-Cell Function. Progress in medicinal chemistry. 27. 143–188. 12 indexed citations
19.
Cochrane, David E., William Boucher, & Robert E. Carraway. (1989). Generation of histamine‐releasing activity from serum albumin by medium derived from stimulated neutrophils of rat. British Journal of Pharmacology. 97(2). 524–532. 6 indexed citations
20.
Carraway, Robert E., et al.. (1988). Xenopsin-related peptide generated in avian gastric extracts. Regulatory Peptides. 22(4). 303–314. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026